Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:09 June,2020

Lancet study finds no benefit for hydroxychloroquine in Covid-19 patients

BOSTON: Treatment for Covid-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for Covid-19 patients, according to a large observational study.
The research, published in the journal The Lancet, analysed data from nearly 15,000 patients with Covid-19 who received chloroquine or its analogue hydroxychloroquine, taken with or without the antibiotics azithromycin or clarithromycin, and 81,000 controls. ....read more


DHC: Notice Issued To Delhi Government in PIL Filed By Dr KK Aggarwal against The Delhi Government Order For No COVID Test Of Asymptomatic Patients

The Hon’ble Chief Justice of Delhi High Court and HMJ Prateek Jalan have issued notice, in the PIL filed by Dr KK Aggarwal, Padma Shree Awardee and President of Heart Care Foundation of India (HCFI), against the Delhi Government’s order of not allowing COVID test of asymptomatic patients or pre-symptomatic patients in Delhi.
Delhi Government has been asked to give its report before the next date of hearing, i.e. 22nd June, 2020. ....read more


World COVID Meter 8th June - 213 Countries affected: Wear mask at home

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7
Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity
Doubling time: India 14.5 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days
Likely minimum deaths (405294 + 53752 x 15 = 8062) = 413357 ....read more


Video of The day
How to handle community transmission of COVID 19


Medbytes

       


Healthcare News Monitor

A Bangladesh pharma company causes heartburn in India's drugmakers

Money Controlviswanath pilla

The Maharashtra government's decision to import Gilead's antiviral drug Remdesivir from Bangladesh drug maker Eskayef Pharmaceuticals has taken the Indian pharmaceutical industry by surprise.
But analysts and legal experts pointed out that it is perfectly legal to import the drug if it is not for commercial use.
On June 6, Rajesh Tope, Maharashtra Health Minister, said the state would buy remdesivir from Dhaka-based Eskayef Pharma for Rs 12,000 per vial for 10,000 doses.

Sebi censures Astrazeneca Pharma's promoter, Elliot Group

ETHealth

NEW DELHI: Markets regulator Sebi has strongly "censured" Astrazeneca Pharma India Ltd's promoter and Elliot Group for professional misconduct and following unfair trade practices during the company's delisting plan in 2014.
The regulator, in a 65-page order, said that Astrazeneca Pharma India Ltd's (AZPIL) promoter AstraZeneca Pharmaceuticals AB Sweden (AZPAB), and Elliott Group, which held 15.52 per cent stake in the company, had a 'private arrangement' to sail through the delisting process.

Coronavirus spotlights why we need to reform medical education | Opinion

VS?Pandey

India is in the 77th day of the lockdown with the economy slowly limping back to normalcy. Concerns are being raised due to an increase in the number of coronavirus infected people across the country, which stands at more than 2,65,000 with 7,466 deaths. Some are even accusing the governments of not listening to expert advice and allowing the resumption of economic activities without making a complete assessment. Questions are also being raised about the rationality and efficacy of the decision to impose complete lockdown from 25 March, when India had reported only 500-odd coronavirus cases and opening the economy when the number of corona infected people started rising , the government has decided to allow opening up of the economy in all respects with fewer restrictions. Apparently the argument seems logical until we compare the Indian scenario with what is happening in other major countries around the world.

Are you a resident doctor? This is the best state for you to practice
DH Web Desk

With the worsening coronavirus situation in the country, frontliners are putting their best foot forward to make sure everyone is safe. Among these frontliners, resident doctors and interns attend to COVID-19 patients for hours daily. Their salary, h...
According to a report by The Times of India, Delhi, Uttar Pradesh and Bihar pay resident doctors the most, whereas, they are paid the worst in Maharashtra at different levels in state government-run hospitals.